SAMN30312318
External Id
Doug Higgs, Weatherall Institute of Molecular Medicine, University of Oxford
INSDC center name
2022-08-18T00:50:19.173Z
INSDC first public
2022-08-18T00:50:19.173Z
INSDC last update
SRS14649170
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS14649170
SRA accession
Primary erythroid cells derived from spleen from INVEN APH-treated mice are disaggregated and cells stained with ter119-PE antibody (BD Biosciences at a working concentration of 2ug/ml) then incubated with anti-PE MACS beads (Miltenyi) and purified using LS columns (Miltenyi), all following manufacturor's instructions.
cell type
Ter119+ erythroid cells purified from the spleen of an INVEN Phenylhydrazine APH-treated mice, sample 1
cell type
H3K4me3 Abcam 8580 2.5ug/ml
chip antibody
Mus musculus
http://purl.obolibrary.org/obo/NCBITaxon_10090
organism
mouse derived Erythroid cells
source_name
C57Bl8
strain
APHSpleen_INVEN_Ter119_H3K4me3_1
title
Genome-wide
treatment